227 related articles for article (PubMed ID: 33952321)
1. geneshot: gene-level metagenomics identifies genome islands associated with immunotherapy response.
Minot SS; Barry KC; Kasman C; Golob JL; Willis AD
Genome Biol; 2021 May; 22(1):135. PubMed ID: 33952321
[TBL] [Abstract][Full Text] [Related]
2. A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors.
Shaikh FY; White JR; Gills JJ; Hakozaki T; Richard C; Routy B; Okuma Y; Usyk M; Pandey A; Weber JS; Ahn J; Lipson EJ; Naidoo J; Pardoll DM; Sears CL
Clin Cancer Res; 2021 May; 27(9):2571-2583. PubMed ID: 33593881
[TBL] [Abstract][Full Text] [Related]
3. The microbial metabolite desaminotyrosine enhances T-cell priming and cancer immunotherapy with immune checkpoint inhibitors.
Joachim L; Göttert S; Sax A; Steiger K; Neuhaus K; Heinrich P; Fan K; Orberg ET; Kleigrewe K; Ruland J; Bassermann F; Herr W; Posch C; Heidegger S; Poeck H
EBioMedicine; 2023 Nov; 97():104834. PubMed ID: 37865045
[TBL] [Abstract][Full Text] [Related]
4. Clustering co-abundant genes identifies components of the gut microbiome that are reproducibly associated with colorectal cancer and inflammatory bowel disease.
Minot SS; Willis AD
Microbiome; 2019 Aug; 7(1):110. PubMed ID: 31370880
[TBL] [Abstract][Full Text] [Related]
5. Gut microbial structural variation associates with immune checkpoint inhibitor response.
Liu R; Zou Y; Wang WQ; Chen JH; Zhang L; Feng J; Yin JY; Mao XY; Li Q; Luo ZY; Zhang W; Wang DM
Nat Commun; 2023 Nov; 14(1):7421. PubMed ID: 37973916
[TBL] [Abstract][Full Text] [Related]
6. Commensal microbiota contributes to predicting the response to immune checkpoint inhibitors in non-small-cell lung cancer patients.
Zhang C; Wang J; Sun Z; Cao Y; Mu Z; Ji X
Cancer Sci; 2021 Aug; 112(8):3005-3017. PubMed ID: 34028936
[TBL] [Abstract][Full Text] [Related]
7. A framework for the targeted recruitment of crop-beneficial soil taxa based on network analysis of metagenomics data.
Berihu M; Somera TS; Malik A; Medina S; Piombo E; Tal O; Cohen M; Ginatt A; Ofek-Lalzar M; Doron-Faigenboim A; Mazzola M; Freilich S
Microbiome; 2023 Jan; 11(1):8. PubMed ID: 36635724
[TBL] [Abstract][Full Text] [Related]
8. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details.
Feigelman R; Kahlert CR; Baty F; Rassouli F; Kleiner RL; Kohler P; Brutsche MH; von Mering C
Microbiome; 2017 Feb; 5(1):20. PubMed ID: 28187782
[TBL] [Abstract][Full Text] [Related]
9. Application of metagenomics in the human gut microbiome.
Wang WL; Xu SY; Ren ZG; Tao L; Jiang JW; Zheng SS
World J Gastroenterol; 2015 Jan; 21(3):803-14. PubMed ID: 25624713
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiome in modulating immune checkpoint inhibitors.
Li X; Zhang S; Guo G; Han J; Yu J
EBioMedicine; 2022 Aug; 82():104163. PubMed ID: 35841869
[TBL] [Abstract][Full Text] [Related]
11. Microbial Influences on Immune Checkpoint Inhibitor Response in Melanoma: The Interplay between Skin and Gut Microbiota.
Bouferraa Y; Fares C; Bou Zerdan M; Boyce Kennedy L
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298653
[TBL] [Abstract][Full Text] [Related]
12. Metagenome-assembled genome binning methods with short reads disproportionately fail for plasmids and genomic Islands.
Maguire F; Jia B; Gray KL; Lau WYV; Beiko RG; Brinkman FSL
Microb Genom; 2020 Oct; 6(10):. PubMed ID: 33001022
[TBL] [Abstract][Full Text] [Related]
13. Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite.
Renga G; Nunzi E; Pariano M; Puccetti M; Bellet MM; Pieraccini G; D'Onofrio F; Santarelli I; Stincardini C; Aversa F; Riuzzi F; Antognelli C; Gargaro M; Bereshchenko O; Ricci M; Giovagnoli S; Romani L; Costantini C
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35236743
[TBL] [Abstract][Full Text] [Related]
14. xenoGI: reconstructing the history of genomic island insertions in clades of closely related bacteria.
Bush EC; Clark AE; DeRanek CA; Eng A; Forman J; Heath K; Lee AB; Stoebel DM; Wang Z; Wilber M; Wu H
BMC Bioinformatics; 2018 Feb; 19(1):32. PubMed ID: 29402213
[TBL] [Abstract][Full Text] [Related]
15. A genome-phenome association study in native microbiomes identifies a mechanism for cytosine modification in DNA and RNA.
Yang W; Lin YC; Johnson W; Dai N; Vaisvila R; Weigele P; Lee YJ; Corrêa IR; Schildkraut I; Ettwiller L
Elife; 2021 Nov; 10():. PubMed ID: 34747693
[TBL] [Abstract][Full Text] [Related]
16. Complex interactions between the microbiome and cancer immune therapy.
Schwartz DJ; Rebeck ON; Dantas G
Crit Rev Clin Lab Sci; 2019 Dec; 56(8):567-585. PubMed ID: 31526274
[TBL] [Abstract][Full Text] [Related]
17. Use of whole genome shotgun metagenomics: a practical guide for the microbiome-minded physician scientist.
Ma J; Prince A; Aagaard KM
Semin Reprod Med; 2014 Jan; 32(1):5-13. PubMed ID: 24390915
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers.
Mao J; Wang D; Long J; Yang X; Lin J; Song Y; Xie F; Xun Z; Wang Y; Wang Y; Li Y; Sun H; Xue J; Song Y; Zuo B; Zhang J; Bian J; Zhang T; Yang X; Zhang L; Sang X; Zhao H
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34873013
[TBL] [Abstract][Full Text] [Related]
19. TIGIT
Tsakmaklis A; Farowski F; Zenner R; Lesker TR; Strowig T; Schlößer H; Lehmann J; von Bergwelt-Baildon M; Mauch C; Schlaak M; Knuever J; Schweinsberg V; Heinzerling LM; Vehreschild MJGT
BMC Cancer; 2023 Nov; 23(1):1160. PubMed ID: 38017389
[TBL] [Abstract][Full Text] [Related]
20. Recovery of strain-resolved genomes from human microbiome through an integration framework of single-cell genomics and metagenomics.
Arikawa K; Ide K; Kogawa M; Saeki T; Yoda T; Endoh T; Matsuhashi A; Takeyama H; Hosokawa M
Microbiome; 2021 Oct; 9(1):202. PubMed ID: 34641955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
